Literature DB >> 20182588

Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.

Mackenzie Cook1, Xiao-Min Yu, Herbert Chen.   

Abstract

The Notch pathway plays an important role in the normal development of neuroendocrine cells, including the calcitonin producing C-cells of the thyroid. This effect has been elucidated to be mediated through modulation of Achaete-Scute Complex Like 1 (ASCL1), a transcription factor associated with poor prognosis in neuroendocrine cancer. Medullary thyroid cancer (MTC) is one of the neuroendocrine cancers derived from the thyroid C-cells. The Notch pathway has been shown to be inactive in MTC which may lead to altered expression of ASCL1. Artificial induction of Notch signaling in MTC cells can suppress ASCL1 expression, the cell growth as well as hormone secreting potential. Pharmacological activation of the Notch pathway also successfully suppresses the tumor growth in an animal model, which sheds light on the targeted therapy of Notch as a potential treatment for intractable MTC.

Entities:  

Keywords:  Notch; achaete-scute complex Like 1; medullary thyroid cancer

Year:  2010        PMID: 20182588      PMCID: PMC2826828     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  46 in total

Review 1.  Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling.

Authors:  Mark E Fortini
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 2.  Notch signaling: the demise of elegant simplicity.

Authors:  Tom Kadesch
Journal:  Curr Opin Genet Dev       Date:  2004-10       Impact factor: 5.578

Review 3.  Current diagnosis and management of medullary thyroid carcinoma.

Authors:  D Giuffrida; H Gharib
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

4.  Suberoyl bishydroxamic acid inhibits cellular proliferation by inducing cell cycle arrest in carcinoid cancer cells.

Authors:  David Yu Greenblatt; Max Cayo; Li Ning; Renata Jaskula-Sztul; Megan Haymart; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Gastrointest Surg       Date:  2007-09-15       Impact factor: 3.452

5.  Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.

Authors:  Li Ning; Renata Jaskula-Sztul; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2008-06-18       Impact factor: 5.344

Review 6.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

7.  Current management of medullary thyroid cancer.

Authors:  Rebecca S Sippel; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Oncologist       Date:  2008-05

8.  Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium.

Authors:  T Ito; N Udaka; T Yazawa; K Okudela; H Hayashi; T Sudo; F Guillemot; R Kageyama; H Kitamura
Journal:  Development       Date:  2000-09       Impact factor: 6.868

9.  Multi-targeted approach in the treatment of thyroid cancer.

Authors:  Scott N Pinchot; Rebecca S Sippel; Herbert Chen
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

10.  Development of chromaffin cells depends on MASH1 function.

Authors:  Katrin Huber; Barbara Brühl; François Guillemot; Eric N Olson; Uwe Ernsberger; Klaus Unsicker
Journal:  Development       Date:  2002-10       Impact factor: 6.868

View more
  11 in total

Review 1.  Signaling mechanisms in neuroendocrine tumors as targets for therapy.

Authors:  Barbara Zarebczan; Herbert Chen
Journal:  Endocrinol Metab Clin North Am       Date:  2010-12       Impact factor: 4.741

2.  Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.

Authors:  Xiao-Min Yu; TramAnh Phan; Priyesh N Patel; Renata Jaskula-Sztul; Herbert Chen
Journal:  Cancer       Date:  2012-09-18       Impact factor: 6.860

3.  Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.

Authors:  Renata Jaskula-Sztul; Jacob Eide; Sara Tesfazghi; Ajitha Dammalapati; April D Harrison; Xiao-Min Yu; Casi Scheinebeck; Gabrielle Winston-McPherson; Kevin R Kupcho; Matthew B Robers; Amrit K Hundal; Weiping Tang; Herbert Chen
Journal:  Mol Cancer Ther       Date:  2014-12-15       Impact factor: 6.261

4.  Induction of apoptosis and autophagy in metastatic thyroid cancer cells by valproic acid (VPA).

Authors:  Yuan Xu; Duo Xu; Shao-Jun Zhu; Bing Ye; Jian-Da Dong; Yin-Long Zhang; Yi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.

Authors:  Dongwon Choi; Swapnika Ramu; Eunkyung Park; Eunson Jung; Sara Yang; Wonhyeuk Jung; Inho Choi; Sunju Lee; Kyu Eui Kim; Young Jin Seong; Mingu Hong; George Daghlian; Daniel Kim; Eugene Shin; Jung In Seo; Vicken Khatchadourian; Mengchen Zou; Wei Li; Roger De Filippo; Paul Kokorowski; Andy Chang; Steve Kim; Ana Bertoni; Tania Weber Furlanetto; Sung Shin; Meng Li; Yibu Chen; Alex Wong; Chester Koh; Jan Geliebter; Young-Kwon Hong
Journal:  Cancer Res       Date:  2015-11-25       Impact factor: 12.701

Review 6.  Notch Signaling in Thyroid Cancer.

Authors:  Rachael Guenter; Zeelu Patel; Herbert Chen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Identification of novel thyroid cancer-related genes and chemicals using shortest path algorithm.

Authors:  Yang Jiang; Peiwei Zhang; Li-Peng Li; Yi-Chun He; Ru-jian Gao; Yu-Fei Gao
Journal:  Biomed Res Int       Date:  2015-03-22       Impact factor: 3.411

8.  MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.

Authors:  Alf Spitschak; Claudia Meier; Bhavani Kowtharapu; David Engelmann; Brigitte M Pützer
Journal:  Mol Cancer       Date:  2017-01-26       Impact factor: 27.401

Review 9.  Targeted Therapy for Medullary Thyroid Cancer: A Review.

Authors:  S R Priya; Chandra Shekhar Dravid; Raghunadharao Digumarti; Mitali Dandekar
Journal:  Front Oncol       Date:  2017-10-06       Impact factor: 6.244

Review 10.  From fly wings to targeted cancer therapies: a centennial for notch signaling.

Authors:  Panagiotis Ntziachristos; Jing Shan Lim; Julien Sage; Iannis Aifantis
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.